Description

2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]guanidine is a complex, high-purity macrolide-derived guanidine compound of significant interest in advanced research and development. Its intricate structure, featuring multiple chiral centers and functional groups, makes it a valuable intermediate or reference standard for pharmaceutical and biochemical applications. This compound is primarily sought by research institutions, pharmaceutical R&D laboratories, and specialty chemical manufacturers working on novel therapeutics, enzyme inhibitors, or molecular probes.

Application

• Pharmaceutical Research & Development: Serves as a key intermediate or a lead compound in the synthesis of novel macrolide-based therapeutics targeting specific biological pathways.
• Biochemical Research: Used as a high-purity reference standard or molecular probe in enzymatic studies, receptor binding assays, and mechanism-of-action investigations.
• Specialty Chemical Synthesis: Acts as a sophisticated building block for the custom synthesis of complex molecules for advanced material science or agrochemical research.
• Academic Research: Employed in universities and research institutes for studying structure-activity relationships (SAR) of polyfunctional macrolide derivatives.

Basic Information

Product Name	2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]guanidine
CAS No.	47917-41-9
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Guanidine, 2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]-; (4E,20E)-35-Butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexylguanidine; Macrolide guanidine derivative; CAS 47917-41-9
EINECS	Contact for details

Quality Control

Our 2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]guanidine is produced under strict quality management systems to ensure batch-to-batch consistency and high purity. Products undergo rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment to support your research and compliance needs.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the product label or COA. This compound may be hygroscopic; keep the container tightly sealed in a dry environment. For long-term storage, consider inert gas purging.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content	≤ 2.0%
Residual Solvents	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.